HK1096689A1 - New process for the synthesis of perindopril and pharmaceutically- acceptable salts thereof - Google Patents
New process for the synthesis of perindopril and pharmaceutically- acceptable salts thereofInfo
- Publication number
- HK1096689A1 HK1096689A1 HK07101194.5A HK07101194A HK1096689A1 HK 1096689 A1 HK1096689 A1 HK 1096689A1 HK 07101194 A HK07101194 A HK 07101194A HK 1096689 A1 HK1096689 A1 HK 1096689A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- formula
- give
- reacting
- compound
- perindopril
- Prior art date
Links
- IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 title abstract 4
- 229960002582 perindopril Drugs 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- JFVLNTLXEZDFHW-QMMMGPOBSA-N (2s)-2-amino-3-(2-bromophenyl)propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1Br JFVLNTLXEZDFHW-QMMMGPOBSA-N 0.000 abstract 4
- -1 (R)-2-substituted propionyl chloride Chemical class 0.000 abstract 3
- DPBOUPADTRCCIH-LURJTMIESA-N ethyl (2s)-2-aminopentanoate Chemical compound CCC[C@H](N)C(=O)OCC DPBOUPADTRCCIH-LURJTMIESA-N 0.000 abstract 3
- 125000001980 alanyl group Chemical class 0.000 abstract 2
- 238000005859 coupling reaction Methods 0.000 abstract 2
- 125000003387 indolinyl group Chemical class N1(CCC2=CC=CC=C12)* 0.000 abstract 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 abstract 1
- 230000008878 coupling Effects 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000010511 deprotection reaction Methods 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000005951 trifluoromethanesulfonyloxy group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03292864A EP1420028B1 (fr) | 2003-11-19 | 2003-11-19 | Pocédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables |
PCT/FR2004/002936 WO2005054276A1 (fr) | 2003-11-19 | 2004-11-18 | Procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1096689A1 true HK1096689A1 (en) | 2007-06-08 |
Family
ID=32116380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07101194.5A HK1096689A1 (en) | 2003-11-19 | 2007-02-01 | New process for the synthesis of perindopril and pharmaceutically- acceptable salts thereof |
Country Status (29)
Country | Link |
---|---|
US (1) | US7208607B1 (xx) |
EP (1) | EP1420028B1 (xx) |
JP (1) | JP4377412B2 (xx) |
KR (1) | KR100863394B1 (xx) |
CN (1) | CN100447152C (xx) |
AR (1) | AR047312A1 (xx) |
AT (1) | ATE354586T1 (xx) |
AU (1) | AU2004295132B2 (xx) |
BR (1) | BRPI0416746B1 (xx) |
CA (1) | CA2546506C (xx) |
CY (1) | CY1106544T1 (xx) |
DE (1) | DE60311942T2 (xx) |
DK (1) | DK1420028T3 (xx) |
EA (1) | EA010102B1 (xx) |
EG (1) | EG26629A (xx) |
ES (1) | ES2282586T3 (xx) |
GE (1) | GEP20084547B (xx) |
HK (1) | HK1096689A1 (xx) |
MA (1) | MA28144A1 (xx) |
MX (1) | MXPA06005607A (xx) |
MY (1) | MY138550A (xx) |
NO (1) | NO336349B1 (xx) |
NZ (1) | NZ546931A (xx) |
PL (1) | PL210769B1 (xx) |
PT (1) | PT1420028E (xx) |
SI (1) | SI1420028T1 (xx) |
UA (1) | UA83269C2 (xx) |
WO (1) | WO2005054276A1 (xx) |
ZA (1) | ZA200603675B (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60302287T2 (de) * | 2003-08-29 | 2006-08-10 | Les Laboratoires Servier | Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen |
KR20060128976A (ko) | 2003-12-29 | 2006-12-14 | 세프라코 아이엔시. | 피롤 및 피라졸 디에이에이오 억제제 |
CN101553217A (zh) | 2005-07-06 | 2009-10-07 | 塞普拉科公司 | 艾司佐匹克隆与反式4-(3,4-二氯苯基)-1,2,3,4-四氢-n-甲基-1-萘胺或反式4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺的组合以及治疗绝经期和心境障碍、焦虑症和认知障碍的方法 |
CA2636324C (en) | 2006-01-06 | 2012-03-20 | Sepracor Inc. | Cycloalkylamines as monoamine reuptake inhibitors |
US8053603B2 (en) | 2006-01-06 | 2011-11-08 | Sunovion Pharmaceuticals Inc. | Tetralone-based monoamine reuptake inhibitors |
CA2648121C (en) | 2006-03-31 | 2013-08-06 | Sepracor Inc. | Preparation of chiral amides and amines |
US7884124B2 (en) | 2006-06-30 | 2011-02-08 | Sepracor Inc. | Fluoro-substituted inhibitors of D-amino acid oxidase |
US7902252B2 (en) | 2007-01-18 | 2011-03-08 | Sepracor, Inc. | Inhibitors of D-amino acid oxidase |
KR101581289B1 (ko) | 2007-05-31 | 2015-12-31 | 세프라코 아이엔시. | 모노아민 재흡수 억제제로서 페닐 치환된 시클로알킬아민 |
WO2016178591A2 (en) | 2015-05-05 | 2016-11-10 | Gene Predit, Sa | Genetic markers and treatment of male obesity |
PH12018502155B1 (en) | 2016-04-20 | 2024-03-27 | Servier Lab | Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid |
CN112047869B (zh) * | 2020-08-20 | 2021-12-21 | 华南理工大学 | 一种氮杂5,6-并环化合物的合成方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2620709B1 (fr) * | 1987-09-17 | 1990-09-07 | Adir | Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese |
-
2003
- 2003-11-19 PT PT03292864T patent/PT1420028E/pt unknown
- 2003-11-19 DK DK03292864T patent/DK1420028T3/da active
- 2003-11-19 AT AT03292864T patent/ATE354586T1/de active
- 2003-11-19 EP EP03292864A patent/EP1420028B1/fr not_active Expired - Lifetime
- 2003-11-19 DE DE60311942T patent/DE60311942T2/de not_active Expired - Lifetime
- 2003-11-19 SI SI200330702T patent/SI1420028T1/sl unknown
- 2003-11-19 ES ES03292864T patent/ES2282586T3/es not_active Expired - Lifetime
-
2004
- 2004-11-18 ZA ZA200603675A patent/ZA200603675B/en unknown
- 2004-11-18 JP JP2006540515A patent/JP4377412B2/ja not_active Expired - Fee Related
- 2004-11-18 UA UAA200606747A patent/UA83269C2/uk unknown
- 2004-11-18 CA CA2546506A patent/CA2546506C/fr not_active Expired - Fee Related
- 2004-11-18 BR BRPI0416746-5A patent/BRPI0416746B1/pt not_active IP Right Cessation
- 2004-11-18 GE GEAP20049463A patent/GEP20084547B/en unknown
- 2004-11-18 WO PCT/FR2004/002936 patent/WO2005054276A1/fr active Application Filing
- 2004-11-18 US US10/580,148 patent/US7208607B1/en not_active Expired - Fee Related
- 2004-11-18 AR ARP040104252A patent/AR047312A1/es not_active Application Discontinuation
- 2004-11-18 AU AU2004295132A patent/AU2004295132B2/en not_active Ceased
- 2004-11-18 MY MYPI20044785A patent/MY138550A/en unknown
- 2004-11-18 EA EA200600898A patent/EA010102B1/ru not_active IP Right Cessation
- 2004-11-18 PL PL380409A patent/PL210769B1/pl unknown
- 2004-11-18 KR KR1020067011929A patent/KR100863394B1/ko not_active IP Right Cessation
- 2004-11-18 NZ NZ546931A patent/NZ546931A/en not_active IP Right Cessation
- 2004-11-18 CN CNB2004800336869A patent/CN100447152C/zh not_active Expired - Fee Related
- 2004-11-18 MX MXPA06005607A patent/MXPA06005607A/es active IP Right Grant
-
2006
- 2006-05-02 MA MA28993A patent/MA28144A1/fr unknown
- 2006-05-16 EG EGPCTNA2006000459A patent/EG26629A/en active
- 2006-06-06 NO NO20062599A patent/NO336349B1/no not_active IP Right Cessation
-
2007
- 2007-02-01 HK HK07101194.5A patent/HK1096689A1/xx not_active IP Right Cessation
- 2007-04-26 CY CY20071100562T patent/CY1106544T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1096689A1 (en) | New process for the synthesis of perindopril and pharmaceutically- acceptable salts thereof | |
CA2073510A1 (en) | Peptidyl derivatives | |
AP1741A (en) | Process for the preparation of high purity perindopril and intermediates useful in the synthesis | |
MA27130A1 (fr) | Nouveau procede de synthese de derives de l'acide (2s,3as,7as)-1-[(s)-alanyl]-octahydro- 1h-indole-2-carboxylique et application a la synthese du perindopril | |
CZ285593B6 (cs) | Způsob výroby (S)-3-amino-1-substituovaných pyrrolidinů | |
JP3872344B2 (ja) | N−〔(s)−1−カルボキシブチル〕−(s)−アラニンエステルの新規合成方法及びペリンドプリルの合成における適用 | |
MA27633A1 (fr) | Nouveau procede de synthese de l'acide (2s)-indoline -2-carboxylique, et application a la synthese du perindopril. | |
UA73562C2 (uk) | Спосіб синтезу n-[(s)-1-карбоксибутил]-(s)-аланінових ефірів і їх застосування у синтезі периндоприлу | |
US7223872B2 (en) | Process for the synthesis of perindopril and its pharmaceutically acceptable salts | |
WO2009098251A1 (en) | NOVEL CYCLOALKANONE β-SUBSTITUTED ALANINE DERIVATIVES | |
US20070043103A1 (en) | Novel metod for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof | |
US7534896B2 (en) | Process for the synthesis of perindopril and its pharmaceutically acceptable salts | |
JP4368304B2 (ja) | アミノ−ピロリジン誘導体を製造するための方法 | |
EP2349998B1 (en) | A novel process for the preparation of eletriptan | |
WO2004078707A3 (fr) | Nouveau procede de synthese de lacide (2s, 3as, 7as)-perhydroindole-2-carboxylique et de ses esters et application a la synthese du perindopril | |
WO2004078708A3 (fr) | Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro,-ih-indole-2-carboxylique et application a la syntrese du perindopril | |
JP4263743B2 (ja) | ペリンドプリル及びその薬学的に許容し得る塩の新規な合成方法 | |
WO2004099138A3 (en) | Process for the preparation of perindopril | |
WO2004082357A3 (fr) | NOUVEAU PROCEDE DE SYNTHESE DE DERIVES DE L'ACIDE (2S, 3aS, 7aS)-1-[(S)-ALANYL]-OCTAHYDRO-lH-INDOLE-2- CARBOXYLIQUE ET APPLICATION A LA SYNTHESE DU PERINDOPRIL | |
US7368580B2 (en) | Method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
JP4608922B2 (ja) | 含窒素複素環化合物の製造方法 | |
MY136549A (en) | NEW PROCESS FOR THE SYNTHESIS OF (2S, 3aS, 7aS)-PERHYDROINDOLE-2-CARBOXYLIC ACID AND ESTERS THEREOF, AND APPLICATION IN THE SYNTHESIS OF PERINDOPRIL | |
MA28223A1 (fr) | NOUVEAU PROCEDE DE SYNTHESE DE DERIVES DE L'ACIDE (2S,3aS,7aS)-1-[(S)-ALANYL]-OCTAHYDRO-1H-INDOLE-2-CARBOXYLIQUE ET APPLICATION A LA SYNTHESE DU PERINDOPRIL |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20181124 |